A Pipeline Teeming with Innovation Beyond todays leading therapies like Mounjaro, Zepbound, Ozempic, and Wegovy, a robust pipeline of next-generation obesity drugs is advancing through clinical development, with several candidates already filed for regulatory approval
Two-tailed paired Students t-test was applied
Reddy's on April 28, 2026 and Apotex's Apo-Semaglutide Injection on May 1, 2026, with seven more submissions still under review
Frequently used in facial serums, scalp products and advanced anti-aging systems
By four to five weeks , when steady-state levels are achieved, the glucose-lowering effects become more consistent and pronounced